Production (Stage)
Lexaria Bioscience Corp.
LEXX
$0.9671
$0.02162.29%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.63M | 6.54M | 8.12M | 6.56M | 8.51M |
| Total Receivables | 358.10K | 331.20K | 263.50K | 154.50K | 208.40K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 823.30K | 850.40K | 444.10K | 1.19M | 379.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.81M | 7.72M | 8.83M | 7.90M | 9.09M |
|
|
|||||
| Total Current Assets | 5.81M | 7.72M | 8.83M | 7.90M | 9.09M |
| Net Property, Plant & Equipment | 354.20K | 383.00K | 398.60K | 389.60K | 362.60K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 516.40K | 506.20K | 505.40K | 516.70K | 498.90K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 64.00K | 64.00K | 64.00K | 63.60K | 63.60K |
| Total Assets | 6.74M | 8.68M | 9.79M | 8.87M | 10.02M |
|
|
|||||
| Total Accounts Payable | 597.50K | 1.28M | 262.10K | 379.90K | 121.30K |
| Total Accrued Expenses | 860.80K | 514.40K | 6.90K | 686.50K | 7.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 29.90K | 29.30K | 28.80K | 28.00K | 27.30K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 5.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 5.00K | -- |
| Total Current Liabilities | 1.49M | 1.82M | 297.80K | 1.10M | 156.00K |
|
|
|||||
| Total Current Liabilities | 1.49M | 1.82M | 297.80K | 1.10M | 156.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 86.70K | 94.40K | 101.90K | 109.30K | 115.30K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.57M | 1.92M | 399.70K | 1.21M | 271.40K |
|
|
|||||
| Common Stock & APIC | 66.40M | 64.24M | 64.06M | 59.62M | 59.52M |
| Retained Earnings | -60.76M | -56.98M | -54.26M | -51.56M | -49.37M |
| Treasury Stock & Other | -81.10K | -118.20K | -23.00K | -19.80K | -21.90K |
| Total Common Equity | 5.55M | 7.14M | 9.77M | 8.04M | 10.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.55M | 7.14M | 9.77M | 8.04M | 10.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -385.60K | -384.00K | -380.30K | -377.30K | -375.60K |
| Total Equity | 5.17M | 6.76M | 9.39M | 7.66M | 9.75M |
|
|
|||||